510(k) Report

510(k) · Cleared

Cleared

EndoChoice Select Injection Needle

K151475510(k) TraditionalCleared Feb 8, 2016251-day reviewClass II21 CFR 876.1500

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Endochoice, Inc. · FBK Endoscopic Injection Needle, Gastroenterology-Urology

Cleared on Feb 8, 2016 as substantially equivalent to K132065 (Endochoice, Inc., 2014) after a 251-day review. Its family tree reaches back 3 generations to 1996.

Decided
Feb 8, 2016
Review
251 days
Class
Class II
Product code
FBK
Recalls
None
Predicates
1

Its longest line of descent runs back 3 generations to K955558 (1996). No later device cites it as a predicate yet.

  1. Root · 3 generations backK955558 Gip/Medi-Globe Sclerotherapy NeedlesMedi-Globe Corp. · 1996
  2. 2 generations backK061222 Injectra Injection NeedleMedi-Globe Corp. · 2006
  3. 1 generation backK132065 Injection NeedleEndochoice, Inc. · 2014
  4. This deviceK151475 EndoChoice Select Injection NeedleEndochoice, Inc. · 2016
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−3K955558Gip/Medi-Globe Sclerotherapy NeedlesMedi-Globe Corp.1996—
−2K061222Injectra Injection NeedleMedi-Globe Corp.2006—
−1K132065Injection NeedleEndochoice, Inc.2014—
0 (this device)K151475EndoChoice Select Injection NeedleEndochoice, Inc.2016—
FIG. 1 — Lineage of K151475, 1996–2016Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in FBK? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new FBK device

  1. #1 K253598 InjecSURE Injection Systemscore 12.9 · 7 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K132065Injection Needle
Summary page 5
…ial Equivalence 7.1 Predicate devices The modified EndoChoice Select Injection needle is substantially equivalent to the predicate devices, EndoChoice Injection Needle (K132065) manufactured by EndoChoice, Inc. The intended use, design and materials and labeling are all substantially equivalent. The pred…
Endochoice, Inc.2014—

Also cleared against K132065: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 20 years and passes through 2 companies; a new generation was cleared every 7.5 years on median.
  • None of the 3 ancestors has a recall.
  • 1 other device also cites its predicate K132065.

How does its category compare?

All FBK devices

FBK Endoscopic Injection Needle, Gastroenterology-Urology: FDA decisions, review times, recalls and adverse event reports over 20 years. 2016, this device’s year, is highlighted.

FDA decisions per year · FBK

3in 2025

2008: 12009: 42011: 12012: 22014: 22015: 32016: 22017: 32018: 22019: 12020: 22021: 12022: 62023: 32024: 42025: 32026 (partial year): 2
2007high 6 (2022) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · FBK

155in 2025

2009: 101 days median2015: 103 days median2017: 51 days median2022: 213 days median2023: 177 days median2024: 192 days median2025: 155 days median
2007high 213 (2022) · low 51 (2017)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · FBK

9in 2024

2016: 12021: 202022: 82023: 12024: 92026 (partial year): 1
2007high 20 (2021) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · FBK

81in 2025

2007: 32008: 222009: 122010: 122011: 22012: 22013: 32014: 92015: 42016: 182017: 272018: 92019: 62020: 252021: 342022: 802023: 602024: 942025: 81
2007high 94 (2024) · low 2 (2011)2025

MAUDE reports naming product code FBK, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—03
20081—022
20094101012
20100—012
20111—02
20122—02
20130—03
20142—09
2015310304
20162—118
2017351027
20182—09
20191—06
20202—025
20211—2034
20226213880
20233177160
20244192994
20253155081
20262—1—

What is it indicated for?

The EndoChoice Select injection needle is intended for endoscopic injection into the gastrointestinal mucosa.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K151475: EndoChoice Select Injection Needle.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K151475

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026